130 related articles for article (PubMed ID: 24990295)
1. Biological characterization of cetuximab-conjugated gold nanoparticles in a tumor animal model.
Kao HW; Lin YY; Chen CC; Chi KH; Tien DC; Hsia CC; Lin WJ; Chen FD; Lin MH; Wang HE
Nanotechnology; 2014 Jul; 25(29):295102. PubMed ID: 24990295
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles.
Qian Y; Qiu M; Wu Q; Tian Y; Zhang Y; Gu N; Li S; Xu L; Yin R
Sci Rep; 2014 Dec; 4():7490. PubMed ID: 25502402
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of EGFR-targeted radioimmuno-gold-nanoparticles as a theranostic agent in a tumor animal model.
Kao HW; Lin YY; Chen CC; Chi KH; Tien DC; Hsia CC; Lin MH; Wang HE
Bioorg Med Chem Lett; 2013 Jun; 23(11):3180-5. PubMed ID: 23628334
[TBL] [Abstract][Full Text] [Related]
4. Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice.
Karmani L; Labar D; Valembois V; Bouchat V; Nagaswaran PG; Bol A; Gillart J; Levêque P; Bouzin C; Bonifazi D; Michiels C; Feron O; Grégoire V; Lucas S; Vander Borght T; Gallez B
Contrast Media Mol Imaging; 2013; 8(5):402-8. PubMed ID: 23740810
[TBL] [Abstract][Full Text] [Related]
5. Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model.
Karra N; Nassar T; Ripin AN; Schwob O; Borlak J; Benita S
Small; 2013 Dec; 9(24):4221-36. PubMed ID: 23873835
[TBL] [Abstract][Full Text] [Related]
6. Gold nanoparticles and radiofrequency in experimental models for hepatocellular carcinoma.
Raoof M; Corr SJ; Zhu C; Cisneros BT; Kaluarachchi WD; Phounsavath S; Wilson LJ; Curley SA
Nanomedicine; 2014 Aug; 10(6):1121-30. PubMed ID: 24650884
[TBL] [Abstract][Full Text] [Related]
7. Narrow band imaging of squamous cell carcinoma tumors using topically delivered anti-EGFR antibody conjugated gold nanorods.
Puvanakrishnan P; Diagaradjane P; Kazmi SM; Dunn AK; Krishnan S; Tunnell JW
Lasers Surg Med; 2012 Apr; 44(4):310-7. PubMed ID: 22415634
[TBL] [Abstract][Full Text] [Related]
8. Mixed-charge nanoparticles for long circulation, low reticuloendothelial system clearance, and high tumor accumulation.
Liu X; Li H; Chen Y; Jin Q; Ren K; Ji J
Adv Healthc Mater; 2014 Sep; 3(9):1439-47. PubMed ID: 24550205
[TBL] [Abstract][Full Text] [Related]
9. Imaging of epidermal growth factor receptor expression in head and neck cancer with SPECT/CT and 111In-labeled cetuximab-F(ab')2.
van Dijk LK; Hoeben BA; Kaanders JH; Franssen GM; Boerman OC; Bussink J
J Nucl Med; 2013 Dec; 54(12):2118-24. PubMed ID: 24136932
[TBL] [Abstract][Full Text] [Related]
10. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
[TBL] [Abstract][Full Text] [Related]
11. Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy.
Sundarraj S; Thangam R; Sujitha MV; Vimala K; Kannan S
Toxicol Appl Pharmacol; 2014 Mar; 275(3):232-43. PubMed ID: 24467950
[TBL] [Abstract][Full Text] [Related]
12. Effect of Cetuximab-Conjugated Gold Nanoparticles on the Cytotoxicity and Phenotypic Evolution of Colorectal Cancer Cells.
El Hallal R; Lyu N; Wang Y
Molecules; 2021 Jan; 26(3):. PubMed ID: 33499047
[TBL] [Abstract][Full Text] [Related]
13. Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells.
Maya S; Kumar LG; Sarmento B; Sanoj Rejinold N; Menon D; Nair SV; Jayakumar R
Carbohydr Polym; 2013 Apr; 93(2):661-9. PubMed ID: 23499109
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional gold-nanoparticles: A nanovectorization tool for the targeted delivery of novel chemotherapeutic agents.
Fernandes AR; Jesus J; Martins P; Figueiredo S; Rosa D; Martins LM; Corvo ML; Carvalheiro MC; Costa PM; Baptista PV
J Control Release; 2017 Jan; 245():52-61. PubMed ID: 27871990
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles.
Curley SA; Cherukuri P; Briggs K; Patra CR; Upton M; Dolson E; Mukherjee P
J Exp Ther Oncol; 2008; 7(4):313-26. PubMed ID: 19227011
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
Ciardiello F; Bianco R; Damiano V; De Lorenzo S; Pepe S; De Placido S; Fan Z; Mendelsohn J; Bianco AR; Tortora G
Clin Cancer Res; 1999 Apr; 5(4):909-16. PubMed ID: 10213228
[TBL] [Abstract][Full Text] [Related]
17. Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo.
Chattopadhyay N; Fonge H; Cai Z; Scollard D; Lechtman E; Done SJ; Pignol JP; Reilly RM
Mol Pharm; 2012 Aug; 9(8):2168-79. PubMed ID: 22734589
[TBL] [Abstract][Full Text] [Related]
18. Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer.
Chattopadhyay N; Cai Z; Pignol JP; Keller B; Lechtman E; Bendayan R; Reilly RM
Mol Pharm; 2010 Dec; 7(6):2194-206. PubMed ID: 20973534
[TBL] [Abstract][Full Text] [Related]
19. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
[TBL] [Abstract][Full Text] [Related]
20. A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer.
Ashton JR; Gottlin EB; Patz EF; West JL; Badea CT
PLoS One; 2018; 13(11):e0206950. PubMed ID: 30408128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
